HOME >> BIOLOGY >> NEWS
Cholesterol Lowering Drugs Stall Disease Progression In People With Below-Average Blood Cholesterol Level

ing, by whatever means, would have a beneficial effect on the atherosclerosis. But the specific results that we have are for cholesterol lowering with pravastatin. I think it would probably be unwise to generalize much further beyond that," MacMahon says.

Pravastatin is one of a group of cholesterol-lowering drugs known as HMG-CoA reductase inhibitors. They work by interfering with the body's natural ability to make cholesterol.

The new findings have implications for treating patients with average or low cholesterol but who have an elevated risk of heart attack, the nation's leading cause of death, and stroke, the third leading cause of death and the leading cause of serious, long-term disability, he says.

The study was carried out in Auckland, using 522 participants from a larger study of New Zealand and Australian coronary heart disease patients called LIPID (Long-term Intervention with Pravastatin in Ischemic Disease). LIPID ended last summer after six years, a year earlier than planned, when it was found pravastatin lowered the risk of death without causing harm to patients.

MacMahon and his colleagues undertook the smaller study, known as the LIPID Atherosclerosis Substudy, to determine if reducing blood cholesterol in people with low or average levels would reduce the development of atherosclerosis. "At the time we started the study, there was great uncertainty about whether it would be beneficial to lower cholesterol in people who have average cholesterol," MacMahon says. "There really was very little evidence, and of course, most patients with coronary heart disease have cholesterol levels that are fairly average."

Co-authors of the paper are Norman Sharpe, M.D.; Greg Gamble, M.Sc.; Hamish Hart, M.B.; John Scott, M.D.; John Simes, M.D.; and Harvey White, D.Sc.


'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
11-May-1998


Page: 1 2 3

Related biology news :

1. Cholesterol lowering drug effective in treating most common form of multiple sclerosis
2. Cholesterol-independent benefits of statins in cardiac hypertrophy
3. Cholesterol levels not necessarily indicative of cardiac health
4. Women With Low Cholesterol May Be At Risk For Depression And Anxiety
5. Structure Of HDL Cholesterol Determined
6. Discovery Of A Molecule That Controls Bile Acids May Lead To New Cholesterol Drugs
7. Researchers Learn How Nature Produces Cholesterol-Lowering Lovastatin
8. New Insights About Good Cholesterol
9. New Gene May Play Important Role In Regulating HDL, The Good Cholesterol
10. Chinese Condiment Cuts Blood Cholesterol
11. Blue-Green Algae Has Dual Cholesterol Lowering Abilities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... Orbsen ... stromal cell immunotherapies, announced it will move its base of operations from the ... the University’s newly created biotechnology park in Galway, Ireland. , “With four clinical ...
(Date:4/1/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place! Participate in the discussion ... upcoming webinars: , CLINICAL TRIALS , April 2 – They’re Talking. Are You Listening? ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected G-CON Manufacturing, ... facility. The new facility, which will anchor the VelocityTX innovation center in San ... manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary of ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... April 08, 2019 , ... CallTower, a ... the launch of their app integration solution, CT Cloud Unite. CT Cloud ... while using CT Cloud Voice and Skype for Business solutions. This robust integration ...
(Date:4/4/2019)... BOSTON (PRWEB) , ... April 03, 2019 , ... ... leaders together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO ... CEO offers insights into the industry’s challenges and opportunities with high-level panels and ...
(Date:3/27/2019)... ... 27, 2019 , ... Lachman is sponsoring the event on April 1-4, where ... Ireland. The executive team on site will be available to discuss strategies and tactics ... agenda this year. , Executives from Lachman participating at this year’s conference include Fran ...
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale Cloud ... it has extended its managed services offering to include NVIDIA® DGX™ systems. The ... part of the NVIDIA DGX-Ready Data Center program to deliver a Zero DevOps ...
Breaking Biology Technology:
Cached News: